Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E
- PMID: 17245113
- DOI: 10.4161/cc.6.1.3688
Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E
Abstract
The eukaryotic translation initiation factor eIF4E is a potent oncogene. In fact, its overexpression in human cancer often correlates with poor prognosis. Traditionally, eIF4E plays a role in translation initiation where it binds the 5' m7G cap found on mRNAs. More recent studies indicate that a significant fraction of eIF4E (up to 68%) resides in the nucleus where it regulates the nuclear export of specific mRNAs. Additionally, eIF4E may play a role in mRNA sequestration and stability in cytoplasmic processing bodies (P-bodies). Our recent studies suggest that eIF4E governs cell cycle progression and cellular proliferation by coordinately orchestrating the expression of several genes at the post-transcriptional level. Hence, eIF4E functions as a central node of an RNA regulon (described below), which plays an essential role in normal differentiation and development and is frequently dysregulated in cancer. Several cellular factors, such as the promyelocytic leukemia protein PML, modulate the function of this regulon by altering the activity of eIF4E. Here, the physiological implications of these observations are described and the clinical implications of directly targeting eIF4E, and the related regulon, are discussed.
Similar articles
-
eIF4E is a central node of an RNA regulon that governs cellular proliferation.J Cell Biol. 2006 Nov 6;175(3):415-26. doi: 10.1083/jcb.200607020. Epub 2006 Oct 30. J Cell Biol. 2006. PMID: 17074885 Free PMC article.
-
The eukaryotic translation initiation factor eIF4E wears a "cap" for many occasions.Translation (Austin). 2016 Aug 10;4(2):e1220899. doi: 10.1080/21690731.2016.1220899. eCollection 2016. Translation (Austin). 2016. PMID: 28090419 Free PMC article.
-
The emerging roles of translation factor eIF4E in the nucleus.Differentiation. 2002 Mar;70(1):10-22. doi: 10.1046/j.1432-0436.2002.700102.x. Differentiation. 2002. PMID: 11963652 Review.
-
Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment.J Genet Genomics. 2018 Jan 20;45(1):13-24. doi: 10.1016/j.jgg.2018.01.003. Epub 2018 Feb 1. J Genet Genomics. 2018. PMID: 29396141 Review.
-
Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation?Eur J Biochem. 2002 Nov;269(22):5350-9. doi: 10.1046/j.1432-1033.2002.03291.x. Eur J Biochem. 2002. PMID: 12423333 Free PMC article. Review.
Cited by
-
The diversity, plasticity, and adaptability of cap-dependent translation initiation and the associated machinery.RNA Biol. 2020 Sep;17(9):1239-1251. doi: 10.1080/15476286.2020.1766179. Epub 2020 Jun 4. RNA Biol. 2020. PMID: 32496897 Free PMC article. Review.
-
Reduced eukaryotic initiation factor 2Bepsilon-subunit expression suppresses the transformed phenotype of cells overexpressing the protein.Cancer Res. 2008 Nov 1;68(21):8752-60. doi: 10.1158/0008-5472.CAN-08-1042. Cancer Res. 2008. PMID: 18974117 Free PMC article.
-
Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer.Mol Cancer. 2011 Feb 14;10:19. doi: 10.1186/1476-4598-10-19. Mol Cancer. 2011. PMID: 21320304 Free PMC article.
-
Synthetic mRNAs; Their Analogue Caps and Contribution to Disease.Diseases. 2021 Aug 23;9(3):57. doi: 10.3390/diseases9030057. Diseases. 2021. PMID: 34449596 Free PMC article. Review.
-
Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.Oncotarget. 2015 Apr 20;6(11):9488-501. doi: 10.18632/oncotarget.3378. Oncotarget. 2015. PMID: 25839159 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
